Sabizabulin - CAS 1332881-26-1

Sabizabulin (ABI-231) is a potent, orally bioavailable α- and β-tubulin inhibitor that is active against melanoma and prostate cancer cell lines. Sabizabulin inhibits tumor growth and metastatic phenotypes of cervical cancer cells by targeting HPV E6 and E7 and is also being studied in prostate cancer.

Apoptosis, Microtubule Associated, Virus Protease

Microbiology/Virology, Apoptosis, Cytoskeletal Signaling

1332854

0.9979

C21H19N3O4

377.39

COc1cc(cc(OC)c1OC)C(=O)c1c[nH]c(n1)-c1c[nH]c2ccccc12

-20°C

Ice Packs

Small Compound